Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,800
Sort by:
Interventional Oncology Devices Market - 2025-2033
US$ 3,400.00
Interventional Oncology Devices Marketis is growing with a CAGR of 19.50% during the forecast period 2026-2035. The Interventional Oncology Devices Market emerges as a key focus in DataM Intelligence...
July 2026
57 pages
Liquid Biopsy Early Cancer Detection Market - 2026-2035
US$ 3,400.00
Liquid Biopsy Early Cancer Detection Market reached US$ 2.48 billion in 2025 and is expected to reach US$ 7.85 billion by 2035, growing with a CAGR of 12.10% during the forecast period 2026-2035. The...
July 2026
62 pages
Multi Cancer Early Detection Market - 2026-2035
US$ 3,400.00
Multi Cancer Early Detection Marketis is growing with a CAGR of 20.88% during the forecast period 2026-2035. The Multi Cancer Early Detection Market emerges as a key focus in DataM Intelligence latest...
July 2026
54 pages
South Korea Cancer Diagnostics Market Report by Product (Consumables, Instruments), Technology (IVD Testing, Imaging, Biopsy Technique), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Region 2026-2034
US$ 2,999.00
South Korea cancer diagnostics market size reached USD 4.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.32% d...
July 2026
115 pages
Precision Oncology Diagnostics Market Forecasts to 2034 – Global Analysis By Product Type (Companion Diagnostics, Comprehensive Genomic Profiling (CGP), Liquid Biopsy Assays, Single Biomarker Tests, Molecular Diagnostic Tests, Next-Generation Sequencing (NGS)-Based Tests, and Other Product Types), Technology, Biomarker Type, Sample Type, Cancer Type, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Precision Oncology Diagnostics Market is accounted for $8.3 billion in 2026 and is expected to reach $28.6 billion by 2034, growing at a CAGR of 16.7% during t...
June 2026
200 pages
?Breast Cancer Liquid Biopsy Market Report by Product Service (Reagent Kits, Instruments, Services), Circulating Biomaker (Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Extracelluar Vesicles (EVs), and Others), End User (Reference Laboratories, Hospital and Physician Laboratories, and Other), and Region 2026-2034
US$ 2,999.00
The global breast cancer liquid biopsy market size reached USD 173.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 590.8 Million by 2034, exhibiting a growth rate (CAGR...
June 2026
147 pages
Flow Cytometry in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Assays & Kits, Instruments, Reagents & Consumables, Software), By Technology (Cell Based, Bead Based), By Indication (Hematological Malignancies, Solid Tumors), By Application (Translational Research, Clinical Applications), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global flow cytometry market within oncology is projected to expand significantly, increasing from USD 2.41 Billion in 2025 to USD 3.97 Billion by 2031, demonstrating an 8.67% Compound Annual Grow...
May 2026
180 pages
Multicancer Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Laboratory Developed Tests (LDTs), In-Vitro Diagnostics (IVDs)), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Fluorescence In-Situ Hybridization (FISH), Others), By Sample (Tissue, Blood, Saliva and Buccal Swab, Others), By Method (DNA, RNA, Proteins), By Cancer Type (Breast and Gynecologic, Gastrointestinal, Endocrine, Genitourinary, Skin, Brain/Nervous System, Sarcoma, Hematological Malignancies, Lung, Head and Neck, Other Cancer Types), By Application (Clinical, Research), By End User (Hospitals, Diagnostic and Clinical Laboratories, Academic Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global multicancer screening market is anticipated to expand significantly, from USD 1.73 billion in 2025 to USD 4.06 billion by 2031, demonstrating a compound annual growth rate of 15.28%. This g...
May 2026
180 pages
Fluid Biopsy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Other) By Type (Circulating Tumor Cells, Circulating Tumor DNA, Cell-free DNA), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Fluid Biopsy Market is projected to grow from USD 11.92 Billion in 2025 to USD 23.82 Billion by 2031, achieving a compound annual growth rate (CAGR) of 12.23%. This market, also known as li...
May 2026
180 pages
Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Screening (Stool-Based Test, Colonoscopy and Sigmoidoscopy, Others), By Diagnostics (Biomarker Test, Colonoscopy), By End User (Hospitals and Clinics, Clinical Laboratories, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Colorectal Cancer Screening and Diagnostic Market is projected to experience substantial growth, increasing from USD 18.78 billion in 2025 to USD 24.85 billion by 2031, demonstrating a comp...
May 2026
185 pages
Next-Generation Breast Cancer Diagnostic and Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Real-Time PCR, Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Fluorescence In-Situ Hybridization (FISH), Others), By Biomarker (BRCA1/2, ER/PR Receptors, HER-2, Others), By Cancer Sub-Type (Luminal A, Luminal B, Triple Negative/Basal Like, Human Epidermal Growth Factor Receptor 2 (HER-2) Enriched), By Offering (Products, Services), By End User (Hospitals and Clinics, Diagnostic Centers and Reference Labs, Academic and Research Institutes), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Next-Generation Breast Cancer Diagnostic and Screening Market is poised for substantial growth, projected to increase from USD 4.81 Billion in 2025 to USD 8.84 Billion by 2031, at a CAGR of...
May 2026
185 pages
Hemato Oncology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cancer Type (Leukemia, Lymphoma, Myeloproliferative Neoplasms, Other Cancers), By Product (Assay Kits and Reagents, Services), By Technology (PCR, IHC, NGS, Cytogenetics, Other) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hemato Oncology Testing Market is set for significant expansion, projected to grow from USD 3.21 Billion in 2025 to USD 5.37 Billion by 2031, achieving an 8.95% CAGR. This market centers on...
May 2026
180 pages
Multi Cancer Early Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End-user (Hospitals, Diagnostic Laboratories, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Multi Cancer Early Detection (MCED) Market is projected to expand significantly, growing from USD 1061.14 Million in 2025 to USD 1798.33 Million by 2031, reflecting a 9.19% Compound Annual...
May 2026
180 pages
